Beranda300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Tutup sebelumnya
¥18,29
Rentang hari
¥18,16 - ¥18,85
Rentang tahun
¥12,93 - ¥34,18
Kapitalisasi pasar
20,66 M CNY
Volume Rata-Rata
18,60 jt
Rasio P/E
41,07
Hasil dividen
2,05%
Bursa utama
SHE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 816,14 jt | 11,21% |
Biaya operasional | 441,56 jt | 6,14% |
Laba bersih | 185,76 jt | -0,46% |
Margin laba bersih | 22,76 | -10,50% |
Penghasilan per saham | 0,16 | -2,13% |
EBITDA | 348,52 jt | 22,34% |
Tarif pajak efektif | 6,09% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 310,71 jt | -70,41% |
Total aset | 14,52 M | -1,41% |
Total liabilitas | 4,81 M | -6,59% |
Total ekuitas | 9,71 M | — |
Saham yang beredar | 1,12 M | — |
Harga terhadap nilai buku | 2,10 | — |
Tingkat pengembalian aset | 5,17% | — |
Tingkat pengembalian modal | 6,38% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 185,76 jt | -0,46% |
Kas dari operasi | 178,68 jt | -37,64% |
Kas dari investasi | -262,60 jt | -774,60% |
Kas dari pembiayaan | -42,46 jt | -25.008,80% |
Perubahan kas bersih | -126,53 jt | -149,37% |
Arus kas bebas | -1,95 M | -214,48% |
Tentang
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Didirikan
8 Sep 1992
Situs
Karyawan
1.902
